pMHC,CD4-CD3-TCR仿

Zachary A Rollins1, Roland Faller1, Steven C George2

  • 1Department of Chemical Engineering, University of California, Davis, Davis, California.

Biophysical journal
|June 29, 2023
PubMed
概括

CD4核受体使主要基因相容复合体 (pMHC) 更接近T细胞受体 (TCR),增强T细胞信号传递和稳定性. 这种原子层面的洞察力有助于设计出更好的免疫疗法.